Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate

B Abrahamsen; Erik Grove; P Vestergaard

doi:10.1007/s00198-013-2469-4

Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate

B Abrahamsen, Erik Grove, P Vestergaard

72 Citationer (Scopus)

Abstract

National registers showed that a large proportion of patients treated with strontium ranelate have conditions that may now contraindicate use. The risk of death in strontium ranelate-treated patients was significantly higher than that seen in users of other osteoporosis drugs even after adjusting for cardiovascular risk factor profile.

Originalsprog	Engelsk
Tidsskrift	Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Vol/bind	25
Udgave nummer	2
Sider (fra-til)	757-62
Antal sider	6
ISSN	0937-941X
DOI	https://doi.org/10.1007/s00198-013-2469-4
Status	Udgivet - feb. 2014

Adgang til dokumentet

10.1007/s00198-013-2469-4

Andre filer og links

Link to publication in Scopus

Citationsformater

Abrahamsen, B., Grove, E., & Vestergaard, P. (2014). Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 25(2), 757-62. https://doi.org/10.1007/s00198-013-2469-4

Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. / Abrahamsen, B; Grove, Erik; Vestergaard, P.
I: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Bind 25, Nr. 2, 02.2014, s. 757-62.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abrahamsen, B, Grove, E & Vestergaard, P 2014, 'Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate', Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, bind 25, nr. 2, s. 757-62. https://doi.org/10.1007/s00198-013-2469-4

Abrahamsen B, Grove E, Vestergaard P. Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014 feb.;25(2):757-62. doi: 10.1007/s00198-013-2469-4

Abrahamsen, B ; Grove, Erik ; Vestergaard, P. / Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. I: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014 ; Bind 25, Nr. 2. s. 757-62.

@article{2c380af8dfc544939642d6032daa4fc4,

title = "Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate",

abstract = "National registers showed that a large proportion of patients treated with strontium ranelate have conditions that may now contraindicate use. The risk of death in strontium ranelate-treated patients was significantly higher than that seen in users of other osteoporosis drugs even after adjusting for cardiovascular risk factor profile.",

author = "B Abrahamsen and Erik Grove and P Vestergaard",

year = "2014",

month = feb,

doi = "10.1007/s00198-013-2469-4",

language = "English",

volume = "25",

pages = "757--62",

journal = "Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA",

issn = "0937-941X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "2",

}

TY - JOUR

T1 - Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate

AU - Abrahamsen, B

AU - Grove, Erik

AU - Vestergaard, P

PY - 2014/2

Y1 - 2014/2

N2 - National registers showed that a large proportion of patients treated with strontium ranelate have conditions that may now contraindicate use. The risk of death in strontium ranelate-treated patients was significantly higher than that seen in users of other osteoporosis drugs even after adjusting for cardiovascular risk factor profile.

AB - National registers showed that a large proportion of patients treated with strontium ranelate have conditions that may now contraindicate use. The risk of death in strontium ranelate-treated patients was significantly higher than that seen in users of other osteoporosis drugs even after adjusting for cardiovascular risk factor profile.

UR - https://www.scopus.com/pages/publications/84899050195

U2 - 10.1007/s00198-013-2469-4

DO - 10.1007/s00198-013-2469-4

M3 - Journal article

C2 - 24322475

SN - 0937-941X

VL - 25

SP - 757

EP - 762

JO - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

JF - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

IS - 2

ER -

Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater